(0.45%) 5 151.07 points
(0.51%) 38 874 points
(0.32%) 16 209 points
(0.68%) $78.64
(3.69%) $2.22
(1.07%) $2 333.20
(3.38%) $27.59
(0.82%) $973.25
(-0.15%) $0.927
(-0.55%) $10.81
(-0.30%) $0.795
(-0.11%) $91.35
Live Chart Being Loaded With Signals
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 543 145 |
Vidutinė apimtis | 3.71M |
Rinkos kapitalizacija | 4.52M |
EPS | $0 ( 2024-03-19 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.436 |
ATR14 | $0.224 (224.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-05 | Goldentree Asset Management Lp | Buy | 75 000 | Ordinary Shares |
2023-12-04 | Goldentree Asset Management Lp | Buy | 0 | Ordinary Shares |
2023-11-14 | Zinman Jon | Buy | 0 | |
2023-11-14 | Stetson David J. | Buy | 0 | |
2023-11-14 | Bracebridge Capital, Llc | Buy | 1 093 857 | New Common Stock |
INSIDER POWER |
---|
-27.49 |
Last 92 transactions |
Buy: 3 785 978 | Sell: 4 853 818 |
Tūris Koreliacija
Mallinckrodt plc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Mallinckrodt plc Koreliacija - Valiuta/Žaliavos
Mallinckrodt plc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $2.21B |
Bruto pelnas: | $891.70M (40.37 %) |
EPS: | $-8.47 |
FY | 2022 |
Pajamos: | $2.21B |
Bruto pelnas: | $891.70M (40.37 %) |
EPS: | $-8.47 |
FY | 2021 |
Pajamos: | $2.21B |
Bruto pelnas: | $891.70M (40.37 %) |
EPS: | $-8.47 |
FY | 2020 |
Pajamos: | $2.21B |
Bruto pelnas: | $669.40M (30.24 %) |
EPS: | $-11.18 |
Financial Reports:
No articles found.
Mallinckrodt plc
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.